SMTL ID : 6lvm.1

Crystal structure of FGFR3 in complex with pyrimidine derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

monomer

Ligands

1 x EVR: 2-[[5-[2-(3,5-dimethoxyphenyl)ethyl]-2-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]pyrimidin-4-yl]amino]-N-ethyl-benzenesulfonamide(Non-covalent)

EVR.1: 23 residues within 4Å: Chain A: L.32, G.33, E.34, G.35, V.40, A.60, K.62, E.79, M.83, I.93, V.107, V.109, E.110, Y.111, A.112, G.115, N.116, R.175, N.176, L.178, A.188, D.189, F.190 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.32, A:L.32, A:V.40, A:A.60, A:I.93, A:V.109, A:Y.111, A:A.188 Hydrogen bonds: A:K.62, A:E.79, A:A.112, A:A.112, A:D.189, A:F.190 pi-Cation interactions: A:K.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuriwaki, I. et al., Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2. Bioorg.Med.Chem. (2020)

Release Date

2020-04-08

Peptides

Fibroblast growth factor receptor 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 3

Related Entries With Identical Sequence